메뉴 건너뛰기




Volumn 27, Issue 5, 2013, Pages 273-280

Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy

Author keywords

Anti CD20 monoclonal antibody; Azathioprine; B cell; Prednisone; Safety

Indexed keywords

ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; DIPHENHYDRAMINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G; PREDNISONE; RITUXIMAB; TRANSCRIPTION FACTOR FOXP3;

EID: 84877603475     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/512624     Document Type: Article
Times cited : (142)

References (39)
  • 1
    • 0036322130 scopus 로고    scopus 로고
    • Diagnosis and treatment of autoimmune hepatitis
    • Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97.
    • (2002) Hepatology , vol.36 , pp. 479-497
    • Czaja, A.J.1    Freese, D.K.2
  • 3
    • 77952711598 scopus 로고    scopus 로고
    • Diagnosis and management of autoimmune hepatitis
    • Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-213.
    • (2010) Hepatology , vol.51 , pp. 2193-2213
    • Manns, M.P.1    Czaja, A.J.2    Gorham, J.D.3
  • 4
    • 0028656460 scopus 로고
    • Cyclosporine in the management of corticosteroid-resistant type i autoimmune chronic active hepatitis
    • Sherman KE, Narkewicz M, Pinto PC. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis. J Hepatol 1994; 21: 1040-7.
    • (1994) J Hepatol , vol.21 , pp. 1040-1047
    • Sherman, K.E.1    Narkewicz, M.2    Pinto, P.C.3
  • 5
    • 0029024492 scopus 로고
    • Tacrolimus: A potential new treatment for autoimmune chronic active hepatitis: Results of an open-label preliminary trial
    • Van Thiel DH, Wright H, Carroll P, et al. Tacrolimus: A potential new treatment for autoimmune chronic active hepatitis: Results of an open-label preliminary trial. Am J Gastroenterol 1995; 90: 771-6.
    • (1995) Am J Gastroenterol , vol.90 , pp. 771-776
    • Van Thiel, D.H.1    Wright, H.2    Carroll, P.3
  • 6
    • 0030034461 scopus 로고    scopus 로고
    • The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine
    • Pratt DS, Flavin DP, Kaplan MM. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 1996; 110: 271-4.
    • (1996) Gastroenterology , vol.110 , pp. 271-274
    • Pratt, D.S.1    Flavin, D.P.2    Kaplan, M.M.3
  • 7
    • 8544229063 scopus 로고    scopus 로고
    • Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis - Report of three cases
    • Kanzler S, Gerken G, Dienes HP, Meyer zum Buschenfelde KH, Lohse AW. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis - report of three cases. Z Gastroenterol 1997; 35: 571-578.
    • (1997) Z Gastroenterol , vol.35 , pp. 571-578
    • Kanzler, S.1    Gerken, G.2    Dienes, H.P.3    Meyer Zum Buschenfelde, K.H.4    Lohse, A.W.5
  • 8
    • 0032403227 scopus 로고    scopus 로고
    • Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate
    • Burak KW, Urbanski SJ, Swain MG. Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate. J Hepatol 1998; 29: 990-3.
    • (1998) J Hepatol , vol.29 , pp. 990-993
    • Burak, K.W.1    Urbanski, S.J.2    Swain, M.G.3
  • 9
    • 44649191187 scopus 로고    scopus 로고
    • The use of budesonide in the treatment of autoimmune hepatitis in Canada
    • Zandieh I, Krygier D, Wong V, et al. The use of budesonide in the treatment of autoimmune hepatitis in Canada. Can J Gastroenterol 2008; 22: 388-92.
    • (2008) Can J Gastroenterol , vol.22 , pp. 388-392
    • Zandieh, I.1    Krygier, D.2    Wong, V.3
  • 10
    • 0033845138 scopus 로고    scopus 로고
    • Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine
    • Richardson PD, James PD, Ryder SD. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000; 33: 371-5.
    • (2000) J Hepatol , vol.33 , pp. 371-375
    • Richardson, P.D.1    James, P.D.2    Ryder, S.D.3
  • 11
    • 3042646320 scopus 로고    scopus 로고
    • Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy
    • Devlin SM, Swain MG, Urbanski SJ, Burak KW. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Can J Gastroenterol 2004; 18: 321-6.
    • (2004) Can J Gastroenterol , vol.18 , pp. 321-326
    • Devlin, S.M.1    Swain, M.G.2    Urbanski, S.J.3    Burak, K.W.4
  • 13
    • 33746961890 scopus 로고    scopus 로고
    • Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Esults of a multicenter, randomized, double-blind, placebocontrolled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
    • Cohen SB, Emery P, Greenwald MW, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: esults of a multicenter, randomized, double-blind, placebocontrolled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006; 54: 2793-806.
    • (2006) Arthritis Rheum , vol.54 , pp. 2793-2806
    • Cohen, S.B.1    Emery, P.2    Greenwald, M.W.3
  • 14
    • 79955996011 scopus 로고    scopus 로고
    • Rituximab therapy for autoimmune haematological diseases
    • Barcellini W, Zanella A. Rituximab therapy for autoimmune haematological diseases. Eur J Intern Med 2011; 22: 220-9.
    • (2011) Eur J Intern Med , vol.22 , pp. 220-229
    • Barcellini, W.1    Zanella, A.2
  • 15
    • 77953264702 scopus 로고    scopus 로고
    • Innovative uses of rituximab in dermatology
    • Carr DR, Heffernan MP. Innovative uses of rituximab in dermatology. Dermatol Clin 2010; 28: 547-57.
    • (2010) Dermatol Clin , vol.28 , pp. 547-557
    • Carr, D.R.1    Heffernan, M.P.2
  • 16
    • 84878917142 scopus 로고    scopus 로고
    • B cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid
    • In press)
    • Myers RP SA, Swain MG, Lee SS, Shaheen AAM, Burak KW. B cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid. Am J Gastroenterol 2013 (In press).
    • (2013) Am J Gastroenterol
    • Myers, R.P.S.A.1    Swain, M.G.2    Lee, S.S.3    Shaheen, A.A.M.4    Burak, K.W.5
  • 17
    • 84863072278 scopus 로고    scopus 로고
    • Biochemical and immunological effects of rituximab in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid
    • Tsuda M, Moritoki Y, Lian ZX, et al. Biochemical and immunological effects of rituximab in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid. Hepatology 2012: 55: 512-21.
    • (2012) Hepatology , vol.55 , pp. 512-521
    • Tsuda, M.1    Moritoki, Y.2    Lian, Z.X.3
  • 18
    • 39049095216 scopus 로고    scopus 로고
    • Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response
    • Breedveld F, Agarwal S, Yin M, et al. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response. J Clin Pharmacol 2007; 47: 1119-28.
    • (2007) J Clin Pharmacol , vol.47 , pp. 1119-1128
    • Breedveld, F.1    Agarwal, S.2    Yin, M.3
  • 19
    • 77955895130 scopus 로고    scopus 로고
    • B-cell targeted therapies in human autoimmune diseases: An updated perspective
    • Townsend MJ, Monroe JG, Chan AC. B-cell targeted therapies in human autoimmune diseases: An updated perspective. Immunol Rev 2010; 237: 264-83.
    • (2010) Immunol Rev , vol.237 , pp. 264-283
    • Townsend, M.J.1    Monroe, J.G.2    Chan, A.C.3
  • 20
    • 45249085670 scopus 로고    scopus 로고
    • Rituximab-induced B cell depletion in autoimmune diseases: Potential effects on T cells
    • Liossis SN, Sfikakis PP. Rituximab-induced B cell depletion in autoimmune diseases: Potential effects on T cells. Clin Immunol 2008; 127: 280-5.
    • (2008) Clin Immunol , vol.127 , pp. 280-285
    • Liossis, S.N.1    Sfikakis, P.P.2
  • 21
    • 0032718310 scopus 로고    scopus 로고
    • International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis
    • Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
    • (1999) J Hepatol , vol.31 , pp. 929-938
    • Alvarez, F.1    Berg, P.A.2    Bianchi, F.B.3
  • 22
    • 37248999499 scopus 로고    scopus 로고
    • Rituximab treatment of idiopathic membranous nephropathy
    • Fervenza FC, Cosio FG, Erickson SB, et al. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 2008; 73: 117-25.
    • (2008) Kidney Int , vol.73 , pp. 117-125
    • Fervenza, F.C.1    Cosio, F.G.2    Erickson, S.B.3
  • 23
    • 0028806153 scopus 로고
    • Chronic hepatitis. An update on terminology and reporting
    • Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-17.
    • (1995) Am J Surg Pathol , vol.19 , pp. 1409-1417
    • Batts, K.P.1    Ludwig, J.2
  • 24
    • 33745323050 scopus 로고    scopus 로고
    • Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B
    • Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739-47.
    • (2006) J Immunol , vol.177 , pp. 739-747
    • Xu, D.1    Fu, J.2    Jin, L.3
  • 26
    • 77951974444 scopus 로고    scopus 로고
    • Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease
    • Afif W, Loftus EV Jr, Faubion WA, et al. Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease. Am J Gastroenterol 2010; 105: 1133-9.
    • (2010) Am J Gastroenterol , vol.105 , pp. 1133-1139
    • Afif, W.1    Loftus Jr., E.V.2    Faubion, W.A.3
  • 27
    • 33646809309 scopus 로고    scopus 로고
    • Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: Case report and review of literature
    • Santos ES, Arosemena LR, Raez LE, O'Brien C, Regev A. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: Case report and review of literature. Liver Int 2006; 26: 625-9.
    • (2006) Liver Int , vol.26 , pp. 625-629
    • Santos, E.S.1    Arosemena, L.R.2    Raez, L.E.3    O'Brien, C.4    Regev, A.5
  • 28
    • 53749095755 scopus 로고    scopus 로고
    • Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis
    • Evans JT, Shepard MM, Oates JC, Self SE, Reuben A. Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis. J Clin Gastroenterol 2008; 42: 862-3.
    • (2008) J Clin Gastroenterol , vol.42 , pp. 862-863
    • Evans, J.T.1    Shepard, M.M.2    Oates, J.C.3    Self, S.E.4    Reuben, A.5
  • 29
    • 78751469089 scopus 로고    scopus 로고
    • A case of autoimmune hepatitis treated with rituximab
    • Barth E, Clawson J. A case of autoimmune hepatitis treated with rituximab. Case Rep Gastroenterol 2010; 4: 502-9.
    • (2010) Case Rep Gastroenterol , vol.4 , pp. 502-509
    • Barth, E.1    Clawson, J.2
  • 30
    • 77956643943 scopus 로고    scopus 로고
    • A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis
    • Ferri S, Longhi MS, De Molo C, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010; 52: 999-1007.
    • (2010) Hepatology , vol.52 , pp. 999-1007
    • Ferri, S.1    Longhi, M.S.2    De Molo, C.3
  • 31
    • 33646052605 scopus 로고    scopus 로고
    • Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis
    • Longhi MS, Hussain MJ, Mitry RR, et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006; 176: 4484-91.
    • (2006) J Immunol , vol.176 , pp. 4484-4491
    • Longhi, M.S.1    Hussain, M.J.2    Mitry, R.R.3
  • 33
    • 51649091745 scopus 로고    scopus 로고
    • Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
    • Stasi R, Cooper N, Del Poeta G, et al. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 2008; 112: 1147-50.
    • (2008) Blood , vol.112 , pp. 1147-1150
    • Stasi, R.1    Cooper, N.2    Del Poeta, G.3
  • 34
    • 33947118656 scopus 로고    scopus 로고
    • Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis
    • Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol 2007; 123: 66-73.
    • (2007) Clin Immunol , vol.123 , pp. 66-73
    • Sfikakis, P.P.1    Souliotis, V.L.2    Fragiadaki, K.G.3    Moutsopoulos, H.M.4    Boletis, J.N.5    Theofilopoulos, A.N.6
  • 35
    • 85056071609 scopus 로고    scopus 로고
    • Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
    • Feuchtenberger M, Muller S, Roll P, et al. Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Open Rheumatol J 2008; 2: 81-8.
    • (2008) Open Rheumatol J , vol.2 , pp. 81-88
    • Feuchtenberger, M.1    Muller, S.2    Roll, P.3
  • 36
    • 77955655056 scopus 로고    scopus 로고
    • Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases
    • Koyabu M, Uchida K, Miyoshi H, et al. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases. J Gastroenterol 2010; 45: 732-41.
    • (2010) J Gastroenterol , vol.45 , pp. 732-741
    • Koyabu, M.1    Uchida, K.2    Miyoshi, H.3
  • 37
    • 79958073303 scopus 로고    scopus 로고
    • Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases
    • Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases. Liver Int 2011; 31: 840-9.
    • (2011) Liver Int , vol.31 , pp. 840-849
    • Tacke, F.1    Zimmermann, H.W.2    Berres, M.L.3    Trautwein, C.4    Wasmuth, H.E.5
  • 38
    • 0035111193 scopus 로고    scopus 로고
    • Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes
    • Nishioji K, Okanoue T, Itoh Y, et al. Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin Exp Immunol 2001; 123: 271-9.
    • (2001) Clin Exp Immunol , vol.123 , pp. 271-279
    • Nishioji, K.1    Okanoue, T.2    Itoh, Y.3
  • 39
    • 0034939844 scopus 로고    scopus 로고
    • Overexpression of interferon gamma-inducible protein 10 in the liver of patients with type i autoimmune hepatitis identified by suppression subtractive hybridization
    • Nagayama K, Enomoto N, Miyasaka Y, et al. Overexpression of interferon gamma-inducible protein 10 in the liver of patients with type I autoimmune hepatitis identified by suppression subtractive hybridization. Am J Gastroenterol 2001; 96: 2211-7.
    • (2001) Am J Gastroenterol , vol.96 , pp. 2211-2217
    • Nagayama, K.1    Enomoto, N.2    Miyasaka, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.